Kronox Lab Sciences Board Approves Q1 FY26 Results, Sets AGM for Sep 16
Kronox Lab Sciences approved Q1 FY26 standalone results with total income of ₹2,968.3 Lakhs and profit before tax of ₹981.0 Lakhs. The 17th AGM is scheduled for September 16, 2026, with book closure from September 10-16. Internal and Cost Auditors were re-appointed for FY 2026-27.
The announcement includes the approval of quarterly financial results and the scheduling of the Annual General Meeting, which are material events for shareholders. The re-appointment of auditors is a routine corporate governance matter.
The announcement reports financial results and routine corporate actions like AGM scheduling and auditor re-appointments. The financial performance is presented factually without significant positive or negative commentary.
Kronox Lab Sciences Limited announced the outcome of its Board of Directors meeting held on August 12, 2026. The Board approved the Unaudited Standalone Financial Results for the quarter ended June 30, 2025. The company reported a total income of ₹2,968.3 Lakhs and a profit before tax of ₹981.0 Lakhs for the quarter.
The Board also approved the convening of the 17th Annual General Meeting (AGM) of the Company on Wednesday, September 16, 2026. Consequently, the Register of Members and Share Transfer Books will be closed from September 10, 2026, to September 16, 2026, inclusive, for the AGM and determining entitlement for final dividend, if declared.
Furthermore, the Board re-appointed M/s. Jaimin & Associates as Internal Auditors for the financial year 2026-27 and appointed M/s. Diwanji & Associates as Cost Auditors for the same period. The Board meeting commenced at 02:30 PM and concluded at 04:30 PM.
What to do with a filing like this
Kronox Lab Sciences Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kronox Lab Sciences Limited. Read the original for the full detail.